Thomas Scott Edgington
#105,265
Most Influential Person Now
Thomas Scott Edgington's AcademicInfluence.com Rankings
Thomas Scott Edgingtonphilosophy Degrees
Philosophy
#4232
World Rank
#6678
Historical Rank
Logic
#1736
World Rank
#2572
Historical Rank
Thomas Scott Edgingtonbiology Degrees
Biology
#5489
World Rank
#7981
Historical Rank
Biochemistry
#655
World Rank
#753
Historical Rank
Download Badge
Philosophy Biology
Thomas Scott Edgington's Degrees
- PhD Biochemistry Stanford University
- Doctorate Medicine Stanford University
Why Is Thomas Scott Edgington Influential?
(Suggest an Edit or Addition)Thomas Scott Edgington's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. (1989) (1253)
- Role of tissue factor in embryonic blood vessel development (1996) (721)
- Human Platelets Possess an Inducible and Saturable Receptor Specific for Fibrinogen (1979) (671)
- A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas (2007) (551)
- Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. (1991) (524)
- Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature (1997) (500)
- Lipopolysaccharide Induction of the Tumor Necrosis Factor-α Promoter in Human Monocytic Cells (1997) (482)
- Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. (1994) (452)
- Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites (1991) (401)
- Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. (1992) (395)
- Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen (1988) (382)
- Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. (1980) (342)
- Defense (1994) (325)
- Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin (1989) (315)
- Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade (1987) (295)
- Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy. (2003) (294)
- The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. (1988) (287)
- Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. (1998) (275)
- A recombinant human enzyme for enhanced interstitial transport of therapeutics. (2006) (249)
- AUTOLOGOUS IMMUNE COMPLEX NEPHRITIS INDUCED WITH RENAL TUBULAR ANTIGEN (1968) (241)
- Structural biology of tissue factor, the initiator of thrombogenesis in vivo 1 (1994) (240)
- Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line (1989) (238)
- The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. (1993) (222)
- Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. (1989) (220)
- Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade. (1988) (216)
- Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. (1997) (208)
- Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis. (1975) (201)
- An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH. (1975) (191)
- AUTOLOGOUS IMMUNE COMPLEX NEPHRITIS INDUCED WITH RENAL TUBULAR ANTIGEN (1968) (189)
- A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/CD18). (1990) (188)
- Autologous Immune-Complex Pathogenesis of Experimental Allergic Glomerulonephritis (1967) (184)
- Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein. (1976) (173)
- Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide (1991) (167)
- A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (Mac-1). (1988) (166)
- Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. (1991) (162)
- Lymphocyte cooperation is required for amplification of macrophage procoagulant activity (1980) (160)
- Integrin regulation of leukocyte inflammatory functions. CD11b/CD18 enhancement of the tumor necrosis factor-alpha responses of monocytes. (1993) (159)
- Monoclonal antibody analysis of purified and cell-associated tissue factor. (1988) (158)
- Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis. (1993) (158)
- Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice (1981) (154)
- Insights in Vessel Development and Vascular Disorders Using Targeted Inactivation and Transfer of Vascular Endothelial Growth Factor, the Tissue Factor Receptor, and the Plasminogen System (1997) (129)
- Letter: Radioimmunoassay of fibrinogen-degradation products. (1974) (128)
- Immunological aspects of hepatitis B virus infection. (1975) (128)
- Role of the membrane surface in the activation of human coagulation factor X. (1992) (128)
- Tissue factor is expressed on monocytes during simulated extracorporeal circulation. (1993) (115)
- Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of effector macrophage tissue factor response. (1991) (114)
- Immunochemical heterogeneity of human plasma apolipoprotein B. I. Apolipoprotein B binding of mouse hybridoma antibodies. (1982) (111)
- Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein (1975) (110)
- The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complex. (1998) (110)
- Characterization and isolation of specific renal tubular epithelial antigens. (1967) (105)
- Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms. (2006) (105)
- Characterization of factor VII association with tissue factor in solution. High and low affinity calcium binding sites in factor VII contribute to functionally distinct interactions. (1991) (101)
- High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5). (1994) (101)
- Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits. (1995) (101)
- An Anti-Tissue Factor Monoclonal Antibody which Inhibits TF Vlla Complex Is a Potent Anticoagulant in Plasma (1991) (101)
- Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression (2010) (99)
- Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies. (1986) (98)
- Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII/VIIa protease activity (1984) (97)
- The integrity of the cysteine 186-cysteine 209 bond of the second disulfide loop of tissue factor is required for binding of factor VII. (1991) (96)
- Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin. (1986) (92)
- Functional analysis of the human tissue factor promoter and induction by serum. (1990) (91)
- FACTOR VIII COAGULANT ACTIVITY AND FACTOR VIII-LIKE ANTIGEN: INDEPENDENT MOLECULAR ENTITIES (1973) (91)
- Control of RNA processing by a large non‐coding RNA over‐expressed in carcinomas (2011) (89)
- Factor-VIII-related antigen: multiple molecular forms in human plasma. (1975) (89)
- Tissue factor induction in human monocytes. Two distinct mechanisms displayed by different alloantigen-responsive T cell clones. (1985) (89)
- The assessment by immunofluorescence methods of humoral anti-myelin antibodies in man. (1970) (89)
- Prostate-specific membrane antigen directed selective thrombotic infarction of tumors. (2002) (87)
- Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro. (1981) (86)
- Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease complex. (1992) (84)
- Effector Cell Protease Receptor-1 Is a Vascular Receptor for Coagulation Factor Xa* (1996) (84)
- Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization. (1995) (83)
- Combined functional and immunochemical analysis of normal and abnormal human factor X. (1979) (82)
- Monocyte procoagulant inducing factor: a lymphokine involved in the T cell-instructed monocyte procoagulant response to antigen. (1986) (80)
- The kinetics and metabolic requirements for direct lymphocyte induction of human procoagulant monokines by bacterial lipopolysaccharide. (1981) (79)
- Functional role of asparaginyl endopeptidase ubiquitination by TRAF6 in tumor invasion and metastasis. (2014) (79)
- Mutational mapping of functional residues in tissue factor: identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain. (1994) (79)
- Integrin regulation of an inflammatory effector gene. Direct induction of the tissue factor promoter by engagement of beta 1 or alpha 4 integrin chains. (1995) (77)
- Identification of effector cell protease receptor-1. A leukocyte-distributed receptor for the serine protease factor Xa. (1990) (77)
- Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo. (1973) (75)
- Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells. (1981) (74)
- Sequential imaging of indium-111-labeled monoclonal antibody in human mammary tumors hosted in nude mice. (1984) (74)
- Immune complex-induced human monocyte procoagulant activity. I. a rapid unidirectional lymphocyte-instructed pathway (1981) (73)
- Differences in experimental tumor localization of dual-labeled monoclonal antibody. (1986) (71)
- HUMAN T LYMPHOCYTE "E" ROSETTE FUNCTION (1974) (70)
- Immunochemical heterogeneity of human plasma apolipoprotein B. II. Expression of apolipoprotein B epitopes on native lipoproteins. (1982) (68)
- INTRAHEPATIC EXPRESSION OF SERUM HEPATITIS VIRUS-ASSOCIATED ANTIGENS (1971) (68)
- Evidence for a B lymphocyte defect underlying the anti-X anti-erythrocyte autoantibody response of NZB mice. (1977) (68)
- Regulation of Tissue Factor—Mediated Initiation of the Coagulation Cascade by Cell Surface Grp78 (2005) (67)
- In vivo interrogation of the molecular display of atherosclerotic lesion surfaces. (2003) (66)
- Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells. (1980) (65)
- Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock. (1992) (64)
- Allogeneic induction of the human T cell-instructed monocyte procoagulant response is rapid and is elicited by HLA-DR (1983) (64)
- Tissue factor residues 157-167 are required for efficient proteolytic activation of factor X and factor VII. (1992) (64)
- Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism. (1984) (64)
- Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein. (1978) (61)
- Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. (1991) (61)
- Hybridoma antibodies to human von Willebrand factor (1984) (60)
- Pathology and immunology of age-associated disease of mice and evidence for an autologous immune complex pathogenesis of the associated renal disease (1972) (60)
- Glomerular complement components in human glomerulonephritis. (1974) (59)
- Signal transduction initiated by extracellular nucleotides regulates the high affinity ligand recognition of the adhesive receptor CD11b/CD18. (1990) (59)
- In vivo suppression of the primary immune response by a species of low density serum lipoprotein. (1977) (58)
- A linkage between the hemostatic and immune systems embodied in the fibrinolytic release of lymphocyte suppressive peptides. (1985) (58)
- Antigenic Specificity of Anti-Erythrocyte Autoantibody Responses by NZB Mice: Identification and Partial Characterization of Two Erythrocyte Surface Autoantigens (1972) (57)
- Dissociation of antibody from erythrocyte surfaces by chaotropic ions. (1971) (57)
- Membrane 126-kilodalton phosphoglycoprotein associated with human carcinomas identified by a hybridoma antibody to mammary carcinoma cells. (1983) (55)
- Liver transplantation in the rat. (1966) (54)
- HUMAN BLOOD LYMPHOCTYE CYTOTOXICITY REACTIONS WITH ALLOGENIC ANTISERA * (1964) (54)
- Association of an isomeric species of carcinoembryonic antigen with neoplasia of the gastrointestinal tract. (1975) (53)
- Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections. (1976) (52)
- Conservation of tissue factor primary sequence among three mammalian species. (1991) (50)
- Structurally homologous ligand binding of integrin Mac-1 and viral glycoprotein C receptors. (1991) (50)
- Antibody mapping of tissue factor implicates two different exon-encoded regions in function. (1991) (49)
- Immunochemical heterogeneity of human plasma high density lipoproteins. Identification with apolipoprotein A-I- and A-II-specific monoclonal antibodies. (1985) (48)
- Von Willebrand factor has more than one binding site for platelets. (1984) (47)
- Heterotopic liver transplantation utilizing inbred rat strains. I. Characterization of allogeneic graft rejection and the effects of biliary obstruction and portal vein circulation on liver regeneration. (1968) (47)
- Upregulation of human immunodeficiency virus-1 in chronically infected monocytic cell line by both contact with endothelial cells and cytokines. (1994) (45)
- Key ligand interface residues in tissue factor contribute independently to factor VIIa binding. (1994) (45)
- Heterogeneity of hereditary and acquired factor X deficiencies by combined immunochemical and functional analyses (1985) (45)
- Isolation and characterization of a homogeneous isomeric species of carcinoembryonic antigen: CEA‐S (1975) (45)
- Sequential receptor cascade for coagulation proteins on monocytes. Constitutive biosynthesis and functional prothrombinase activity of a membrane form of factor V/Va. (1989) (43)
- Clinical and immunologic features of transient cold agglutinin-hemolytic anemia. (1973) (42)
- Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain. (1999) (42)
- Macromolecular Substrate Affinity for the Tissue Factor-Factor VIIa Complex Is Independent of Scissile Bond Docking* (1999) (42)
- Microfilament reorganization is associated with functional activation of alpha M beta 2 on monocytic cells. (1994) (41)
- Extrinsic modulation of human T-lymphocyte E rosette function associated with prolonged hepatocellular injury after viral hepatitis. (1977) (41)
- Energetic contributions and topographical organization of ligand binding residues of tissue factor. (1995) (41)
- Regulation of tissue factor gene expression in epithelial cells. Induction by serum and phorbol 12-myristate 13-acetate. (1994) (41)
- Neoantigenic expressions engendered by plasmin cleavage of fibrinogen. (1971) (41)
- Resolution of monomeric and heterodimeric forms of tissue factor, the high-affinity cellular receptor for factor VII. (1988) (41)
- Cyclosporin A regulates monocyte/macrophage effector functions by affecting instructor T cells: inhibition of monocyte procoagulant response to allogeneic stimulation. (1984) (40)
- Initiation of the extrinsic pathway of coagulation. Association of factor VIIa with a cell line expressing tissue factor. (1987) (39)
- Hybridoma antibodies to human von Willebrand factor (1984) (39)
- The instructor cell for the human procoagulant monocyte response to bacterial lipopolysaccharide is a Leu-3a+ T cell by fluorescence-activated cell sorting. (1983) (38)
- Two sites in the tissue factor extracellular domain mediate the recognition of the ligand factor VIIa. (1991) (38)
- Differential sensitivity of lymphocyte subpopulations to suppression by low density lipoprotein inhibitor, an immunoregulatory human serum low density lipoprotein. (1979) (37)
- Surface markers of fibrinogen and its physiologic derivatives revealed by antibody probes. (1982) (37)
- Monoclonal antibody to an activation neoepitope of alpha M beta 2 inhibits multiple alpha M beta 2 functions. (1994) (36)
- Cellular Events Associated with the Immunogenesis of Anti‐Erythrocyte Autoantibody Responses of NZB Mice (1976) (35)
- Endotoxin-induced tissue factor messenger RNA in human monocytes is negatively regulated by a cyclic AMP-dependent mechanism. (1993) (35)
- Effect of LDL-In, a normal immunoregulatory human serum low density lipoprotein, on the interaction of macrophages with lymphocytes proliferating in response to mitogen and allogeneic stimulation. (1977) (34)
- Plasma hemopexin homeostasis during the acute phase response. (1972) (33)
- The molecular biology of initiation of coagulation by tissue factor. (1991) (32)
- Immune complex-induced human monocyte procoagulant activity. II. Cellular kinetics and metabolic requirements. (1982) (32)
- Factor Xa Binding to Annexin 2 Mediates Signal Transduction via Protease-Activated Receptor 1 (2008) (32)
- Plasma lipoproteins with bioregulatory properties including the capacity to regulate lymphocyte function and the immune response. (1981) (31)
- The serine protease cofactor factor V is synthesized by lymphocytes. (1993) (31)
- Immunoregulatory plasma low density lipoprotein: the biologic activity and receptor-binding specificity is independent of neutral lipids. (1981) (31)
- Endotoxin-induced tissue factor messenger RNA in human monocytes is negatively regulated by a cyclic AMP-dependent mechanism (1993) (28)
- Identification of derepressed autoimmunocompetent B lymphoid cells in NZB mice. (1974) (28)
- Discriminating neoantigenic differences between fibrinogen and fibrin derivatives. (1973) (27)
- Conformational and structural modulation of the NH2-terminal regions of fibrinogen and fibrin associated with plasmin cleavage. (1975) (27)
- Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X. (2000) (27)
- Inhibition of lymphocyte protein synthesis by fibrinogen-derived peptides. (1982) (27)
- Lymphocyte suppressive peptides from fibrinogen are derived predominantly from the A alpha chain. (1986) (27)
- A glycoprotein set specifically associated with the surface and cytosol of human breast carcinoma cells. (1978) (26)
- Activation of the coagulation system in association with neoplasia. (1980) (25)
- The biologic activity of the immunoregulatory lipoprotein, LDL-In is independent of its free fatty acid content. (1981) (25)
- Lymphocyte collaboration is required for induction of murine monocyte procoagulant activity by immune complexes. (1981) (25)
- Delineation of spontaneous erythrocyte autoantibody responses of NZB and other strains of mice. (1978) (25)
- A cleavage-associated neoantigenic marker for a gamma chain site in the NH2-terminal aspect of the fibrinogen molecule. (1975) (25)
- A disorder of mucopolysaccharide metabolism with articular, respiratory, and neurologic manifestations (1966) (25)
- Molecular events responsible for modulation of neoantigenic expression: the cleavage-associated neoantigen of fibrinogen (blood coagulation-fibrinogen cleavage products-fibrinolysis-molecular conformation). (1972) (25)
- Dose-dependent modulation of tissue factor protein and procoagulant activity in human monocyte-derived macrophages by oxidized low density lipoprotein. (2011) (24)
- Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa (1996) (23)
- Frequency of association of mammary tumor glycoprotein antigen and other markers with human breast tumors. (1979) (23)
- High Level Expression of Recombinant Human Tissue Factor in Chinese Hamster Ovary Cells as a Human Thromboplastin (1991) (21)
- The pathobiology of viral hepatitis and immunologic activation of the coagulation protease network. (1984) (21)
- A novel vascular endothelial growth factor heparin-binding domain substructure binds to glycosaminoglycans in vivo and localizes to tumor microvascular endothelium. (2002) (21)
- Current status of carcinoembryonic antigen (CEA) and CEA-S assays in the evaluation of neoplasm of the gastrointestinal tract. (1978) (20)
- Clonal analysis of mechanisms of murine T helper cell collaboration with effector cells of macrophage lineage. (1988) (20)
- A distinct "slow" cellular pathway involving soluble mediators for the T cell-instructed induction of monocyte tissue factor activity in an allogeneic immune response. (1984) (20)
- Clonal heterogeneity of the anti-erythrocyte autoantibody responses of NZB mice. (1974) (20)
- Interaction of factor VIII antigen in hemophilic plasmas with human antibodies to factor VIII. (1977) (20)
- Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease. (1979) (20)
- An innate host response to the neoplastic cell: syngeneic rat tumor cells can elicit a rapid de novo lymphoid procoagulant response. (1985) (20)
- Lymphoid procoagulant response to bacterial endotoxin in the rat (1985) (19)
- Initial characterization of a lymphokine pathway for the immunologic induction of tumor necrosis factor-alpha release from human peripheral blood mononuclear cells. (1988) (19)
- The role of afferent blood supply in regeneration of liver isografts in rats. (1968) (19)
- Unique immunochemical features and intracellular stability of platelet fibrinogen. (1975) (19)
- Differentiation of adherent human monocytes into macrophages markedly enhances tissue factor protein expression and procoagulant activity. (2002) (18)
- Cellular pathways and signals for the induction of biosynthesis of initiators of the coagulation protease cascade by cells of the monocyte lineage (1985) (18)
- The third Trp-Lys-Ser (WKS) tripeptide motif in tissue factor is associated with a function site. (1992) (18)
- Influence of mutations in tissue factor on the fine specificity of macromolecular substrate activation. (1997) (18)
- Plasma hemopexin levels following aortic valve replacement: a valuable screening test for assessing the severity of cardiac hemolysis. (1972) (18)
- CD11a/CD18 (LFA-1) integrin engagement enhances biosynthesis of early cytokines by activated T cells. (1993) (17)
- Tissue factor regulation and gene organization. (1989) (17)
- A selective defect in tissue factor mRNA expression in monocytes from AIDS patients. (1990) (17)
- Sufficiency of the CD8+ T cell lineage to mount an effective tumoricidal response to syngeneic tumor-bearing novel class I MHC antigens. (1989) (17)
- Immune responses to the cleavage-associated neoantigens of fibrinogen in man. Identification and characterization of humoral antibodies specific for cleavage fragments. (1975) (17)
- The major histocompatibility complex requirement for cellular collaboration in the murine lymphoid procoagulant response stimulated by bacterial lipopolysaccharide. (1982) (17)
- Immunobiology of the autoantibody response. II. The lipoprotein-associated soluble HB erythrocyte autoantigen of NZB mice. (1973) (17)
- Influence of the immunoregulatory serum lipoprotein LDL-In on the in vivo proliferation and differentiation of antigen-binding and antibody-secreting lymphocytes during a primary immune response. (1980) (17)
- THE D:E COMPLEX: A NATIVE CONFORMATIONAL COMPONENT OF THE FIBRINOGEN MOLECULE (1972) (16)
- The Train Has Left the Station (1994) (16)
- Lymphocyte-instructed monocyte induction of the coagulation pathways parallels the induction of hepatitis by the murine hepatitis virus. (1982) (16)
- Recovery of soluble sheep erythrocyte receptor from the T lymphocyte surface by proteolytic cleavage. (1977) (16)
- Persistence of the autoimmune pathogenetic process in experimental autologous immune complex nephritis. (1969) (16)
- Direct suppression of lymphocyte induction by the immunoregulatory human serum low density lipoprotein, LDL-In. (1980) (16)
- More cellular signals for atherogenesis? (1998) (15)
- Immunobiology of the autoantibody response. I. Circulating analogues of erythrocyte autoantigens and heterogeneity of the autoimmune response of NZB mice. (1973) (15)
- Specific antigen-binding and antibody-secreting lymphocytes associated with the erythrocyte autoantibody responses of NZB and genetically unrelated mice. (1976) (15)
- Purification, sequence and crystallization of an anti-tissue factor Fab and its use for the crystallization of tissue factor (1992) (15)
- Complement-mediated binding of monocytes to intermediate filaments in vitro. (1983) (15)
- The extrinsic coagulation cascade and tissue factor pathway inhibitor in macrophages: a potential therapeutic opportunity for atherosclerotic thrombosis. (2014) (15)
- Tissue Factor residue Asp44 regulates catalytic function of the bound proteinase Factor VIIa. (1996) (14)
- A selective tumor microvasculature thrombogen that targets a novel receptor complex in the tumor angiogenic microenvironment. (2005) (14)
- Molecular interactions of the intrinsic activation complex of coagulation: binding of native and activated human factors IX and X to defined phospholipid vesicles. (1987) (14)
- Immunochemistry of the hepatitis B virus: 125I HB Ag ligand. (1974) (14)
- Characterization of a fragment of bovine von Willebrand factor that binds to platelets. (1986) (13)
- Differences in the characteristics of inhibition of lymphocyte stimulation by 25-hydroxycholesterol and by the immunoregulatory serum lipoprotein LDL-In. (1980) (13)
- Radioimmunoassay for tissue distribution of a human mammary tumor-specific glycoprotein. (1980) (13)
- Clonal analysis of CD4+ T helper cell subsets that induce the monocyte procoagulant response. (1990) (13)
- Steady state levels of factor X mRNA in liver and Hep G2 cells. (1987) (12)
- Two independent sets of monoclonal antibodies define neoepitopes linked to soluble ligand binding and leukocyte adhesion functions of activated alpha M beta 2. (1994) (12)
- The in vivo behavior of the terminal derivatives of fibrinogen and fibrin cleaved by plasmin. (1974) (12)
- Regulatory roles of T mu and T gamma cells in the collaborative cellular initiation of the extrinsic coagulation pathway by bacterial lipopolysaccharide. (1985) (12)
- THE BIOREGULATORY PROPERTIES OF SERUM LOW DENSITY LIPOPROTEIN INHIBITOR (LDL-IN) ON THE GENERATION OF KILLER T CELLS (1977) (11)
- Conformation of the carboxy-terminal region of the A alpha chain of fibrinogen as elucidated by immunochemical analyses. (1984) (11)
- Delineation of three classes of CEA antigenic determinants: identification of membrane-associated CEA as an independent species of CEA. (1977) (11)
- Mutational analysis of receptor and cofactor function of tissue factor. (1993) (11)
- Autologous immune complex glomerulonephritis. 3. Studies on cellular and parabiotic transfer. (1969) (11)
- SECRETORY FUNCTION AND RELATIVE RESISTANCE OF THE GASTRIC MUCOSA OF THE RAT TO ALLOGENEIC REJECTION (1972) (11)
- Immunopathology of glomerulonephritis. (1974) (11)
- Immunochemical mapping of the conformation of human fibrinogen. The gamma 95-264 segment in inaccessible to antibody in native fibrinogen but progressively exposed by plasmic cleavage. (1981) (10)
- Comparative immunochemical characterization of products of plasmin and leukocyte protease cleavage of human fibrinogen. (1978) (10)
- The Immunosuppressive Activity of Plasmic Degradation Products of Human Fibrinogen (1977) (10)
- Localization and characterization of the cleavage-associated neoantigen locus in the E domain of fibrinogen. (1979) (10)
- Functional molecular anatomy of fibrinogen: antibodies as biological probes of structure. (1973) (9)
- Ultramicro Assay of Anti‐Erythrocyte Antibodies and Erythrocyte Antigens 1 (1971) (9)
- Sideroblastic anemia associated with cytogenetic aberrations of bone marrow cells. (1972) (9)
- The number of D and E regions in the fibrinogen molecule. (1974) (9)
- Vascular biology: integrative molecular cell biology (1995) (9)
- Erratum: Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function (The Journal of Biological Chemistry, Vol. 266 (1991) 2158-2166) (1991) (9)
- Characteristics of membrane and cytosol forms of the mammary tumor glycoprotein molecule mtgp in human breast carcinoma cell cultures and tumors (1981) (8)
- Lymphoid procoagulant activity and mitogenesis in the C3H/HeJ mouse: discordant response to lipopolysaccharide stimulation. (1980) (8)
- The influence of CEA-S from different tumors and of CEA as 125I ligands on the specificity of the CEA-S radioimmunoassay. (1976) (8)
- Relationship between antibody affinity and hemolytic plaque diameter. I. Purified anti-DNP antibody. (1979) (8)
- Pathogenesis of anemia associated with Mycoplasma pneumoniae. (1974) (8)
- Amidolytic assay for procoagulant activity of lymphoid and tumor cells. (1986) (7)
- New plasma autoantigen and its role in autoimmune disease of New Zealand Black mice. (1971) (7)
- Structure and In Vivo Behavior of Human Fibrinogen Fragment-D 1 (1972) (7)
- Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor. (2003) (7)
- A comparison of CEA-S and CEA concentrations in sera and the independence of CEA-S, NCA and blood group antigens. (1976) (7)
- Laboratory tests for diagnosis of autoimmune diseases. (1975) (7)
- Subcellular localization of the sedimentable form of mammary tumor glycoprotein to the tumor cell plasmalemma. (1980) (7)
- IMMUNOCHEMICAL ANALYSIS OF THE CONFORMATION OF FIBRINOGEN * (1983) (7)
- Recognition coupled responses of the monocyte: activation of coagulation pathways. (1983) (6)
- So what is critically lacking with coronary atherosclerotic plaques? Perhaps the antithrombotic control. (2001) (6)
- Aberrant maturational characteristics of the immune responses of NZB mice to autologous and heterologous erythrocyte antigens. (1975) (6)
- Internalization of the amino terminal 1-78 sequence of the gamma chain of native fibrinogen and exposure associated with catabolism and plasmin cleavage. (1979) (6)
- Fibrinogen and Fibrin Degradation Products: Their Differentiation (1975) (6)
- Antihepatocyte Antibodies and Hepatitis (1984) (6)
- Monocytes can be induced by lipo poly saccharide stimulated t cells to express factor vii activity (1983) (6)
- Molecular immunology of factor VIII. (1974) (6)
- An immunochemical homology between the Aalpha and a D-E complex-dependent site of the gamma chains of fibrinogen. (1977) (6)
- Steady State Levels of Factor X mRNA in Liver and Hep G2 Cells (1987) (5)
- Multiple Molecular Forms of Factor VIII Antigen in Normal Individuals and Von Willebrand’s Disease Patients (1977) (5)
- Leukaemia inhibitory factor enhances tissue factor expression in human monocyte‐derived macrophages: a gp130‐mediated mechanism (1999) (5)
- Immune Responses and Liver Disease, Perhaps. But What About Target Organ Defenses? (2007) (5)
- Glomerular tissue factor stimulates thromboxane synthesis in human platelets via thrombin generation. (1992) (5)
- Association between the molecular pathobiology of essential hypertension and thrombotic diseases. (2000) (4)
- The D:E complex as a discrete plasmic cleavage product of fibrinogen. (1977) (4)
- SUPPRESSION OF THE IN VIVO HUMORAL IMMUNE RESPONSE BY A SPECIES OF NORMAN HUMAN SERUM LOW DENSITY LIPOPROTEIN (1977) (4)
- Prolonged hypercholesterolemia-induced tissue factor expression in rabbit vein grafts: a potential mechanism for graft failure (2010) (4)
- Aberrant maturation of the immune response to the thymus-independent antigen DNP-Lys--Ficoll by New Zealand Black mice. (1980) (4)
- Platelet-induced expression of tissue factor procoagulant activity in freshly isolated human mononuclear cells: implications for experimental use. (2003) (4)
- Perspectives in inflammation, neoplasia, and vascular cell biology : proceedings of a Triton Biosciences-UCLA Symposium, held in Park City, Utah, February 2-8, 1985 (1987) (3)
- Mono clonal antibodies to human von willebrand factor role of intra molecular loci in mediation of platelet adhesion to the subendothelium (1983) (3)
- Cell surface autoantigenic expressions and their circulating analogues in the pathogenesis of immune injury in nzb mice. Abstr. (1972) (3)
- A hybrid fibronectin motif protein as an integrin targeting selective tumor vascular thrombogen. (2004) (3)
- Perspectives in inflammation, neoplasia and vascular cell biology. Abstracts (1985) (3)
- GEL DOUBLE DIFFUSION TESTING FOR TUBERCULOSIS. (1964) (3)
- Abstracts of papers and posters (2005) (3)
- Surface exposure of the NH2-terminal regions of the B beta chain of the human fibrinogen. (1979) (2)
- Relationship between antibody affinity and hemolytic plaque diameter--II. Maturation of primary immune responses to DNP and SRBC. (1980) (2)
- Heterotopic and orthotopic liver transplants in inbred rat strains (1979) (2)
- Effect of Calcium and magnesium on Receptor Mediated Binding of Fibrinogen by Platelets (1979) (2)
- The Other AIDS Crisis (1995) (2)
- Surfing tissue factor (2007) (2)
- Breast Cancer Markers (1982) (2)
- Pathogenetic Linkages between Gram Negative Septic Shock and the Cellular Initiation and Regulation of Coagulation (1991) (2)
- Erratum: Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progession (Proceedings of the National Academy of Sciences of the United States of America (2010) 107, 24 (10920-10925) DOI: 10.1073/pnas.0914776107) (2010) (1)
- Is Fibrinolysis a Continuous Low Level Mechanism in Normal Adults? (1977) (1)
- Fibrin split products. (1973) (1)
- More inflammatory effects of protease receptors. (1997) (1)
- Enhancement of Tissue Factor Dependent Procoagulant Activity and Factor Xa Generation by Alpha2-Macroglobulin. (2005) (1)
- A RECEPTOR FOR NORMAL HUMAN SERUM LOW DENSITY LIPOPROTEINS ON PERIPHERAL BLOOD LYMPHOCYTES (1977) (1)
- Two populations of autoimmunocompetent anti-erythrocyte plaque forming cells in nzb mice. Abstr. (1973) (1)
- Two monoclonal antibodies against small cytokeratins of mammary carcinoma cell line BT-20 (1984) (1)
- Autologous Immune Complex Glomerulonephritis (1969) (1)
- Common Dollars and Sense (1992) (1)
- The influence of antigen on a model for analysis of multiple coordinate events associated with the primary immune response. (1979) (1)
- Induction of a procoagulant monokine is a marker for susceptibility to murine viral hepatitis. Abstr. (1981) (1)
- Localization and Characterization of the Cleavage-Associated Neoantigen in the Edomain of Fibrinogen (1977) (0)
- Prostate-specific Membrane Antigen Directed Selective Thrombotic Infarction of Tumors 1 (2002) (0)
- Reply from Morrissey and Edgington (1988) (0)
- MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR (1998) (0)
- Binding and Leukocyte Adhesion (2005) (0)
- Effector mechanisms and products of the physiological fibrinolytic systems. (1976) (0)
- NIH Funding Policy (1994) (0)
- Antibodies As Probes Of The Conformation Of Fibrinogen (1981) (0)
- Angiostatic therapy gets moving. (1997) (0)
- The 126 KD Phosphoprotein of Human Breast Carcinoma Cell Surface (1984) (0)
- Inactivation of the tissue factor gene results in embryonic lethality due to abnormal vasculogenesis (1996) (0)
- Visualization of a human mammary tumor in nude mice with In-111 labeled monoclonal antibody (1984) (0)
- with respect to human tissue factor DNA fragment and a recombinant DNA molecule and a method for producing the protein (1988) (0)
- Identification of the major biological effect of ldl-in mediated immunosuppression of the primary immune response in vivo. Abstr. (1979) (0)
- Characterization of the Fibrinolytic Components Specified by Vascular Endothelial Cells (1977) (0)
- EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR (1998) (0)
- A privileged exception of gastric mucosa to allogeneic attack in rats. (1980) (0)
- of a Lymphocyte Surface Receptor for Low Density Lipoprotein Inhibitor, an Immunoregulatory Species of Normal Human Serum Low (1977) (0)
- Immunobiology of the Autoantibody Response (1973) (0)
- Characterization of mhc gene products expressed by auto-antibody-secreting b cells of nzb mice. Abstr. (1979) (0)
- Crystal Structure of tissue factor-factor VIIa complex (2004) (0)
- Discovery and Characterization of a Novel Large Non-Coding RNA Transcript, the Mouse Alpha Gene. (2004) (0)
- Radioimmunoassayfor Tissue Distributionof a Human Mammary Tumor-specificGlycoprotein' (1980) (0)
- Endotoxin triggers tumor necrosis factor (TNF)-dependent cytotoxicity from interferon-. gamma. (IFN-. gamma. ) primed and unprimed human monocytes (1986) (0)
- Looking to the Future of the Life Sciences (1994) (0)
- endotoxin.monocyte procoagulant response to Regulation of tissue factor gene expression in (2013) (0)
- Editorial: The hemophiloid diseases and factor VIII. Clinical molecular biology. (1975) (0)
- Reform of the National Institutes of Health (1992) (0)
- Thrombose cible par de polypeptides du facteur tissulaire (2002) (0)
- The immunoregulatory plasma lipoprotein, ldl-in, is a set of intermediate density lipoprotein: immunochemical evidence using monoclonal antibodies. Abstr. (1981) (0)
- Group Analysis Of Abnormal Factor X Molecules (1981) (0)
- The immune response and alterations induced by immunosuppressive drugs. (1987) (0)
- Intellectual Property Rights (1994) (0)
- A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9) (1998) (0)
- AN IMMUNOLOGIC SPECIFIC METHOD FOR THE ASSAY OF FIBRIN OR FIBRINOGEN CLEAVAGE PRODUCTS (1973) (0)
- 1997 PEDIATRIC ACADEMIC SOCIETIES ’ ANNUAL MEETING SPONSORED BY THE AMERICAN PEDIATRIC Socnrr S 0 cIE ’ rY FOR PEDIATRIC RESEARCH AND AMULATORY PEDIATRIC ASSOCIATION (2004) (0)
- Cytotoxicity triggering factor for tumor necrosis factor alpha related cytotoxicity analysis of molecular weight and functional relationship to other cytokines (1986) (0)
- Localization of a 126 kd plasma membrane phosphoglycoprotein of human mammary carcinoma cell line BT-20 at desmosomal attachment sites (1984) (0)
- Isolation and partial characterization of the soluble erythrocyte autoantigen reactive with anti-erythrocyte autoantibodies from nzb mice. Abstr. (1978) (0)
- Reviewers for DDS—Thank you (2005) (0)
- Democracy in Action? Strategic Reform of NIH (1992) (0)
- Issues in immunologically‐mediated hepatic injury (1981) (0)
- RADIOIMMUNOASSAY OF FIBRINOGENDEGRADATION PRODUCTS (1974) (0)
- Heterotopic Liver Transplantation Utilizing Inbred Rat Strains of AUlogeneic Graft Rejection and the Effects of Biliary Obstlrction and Portal Vein Circulation (2007) (0)
- Correction for Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progession (2010) (0)
- Gel Diffusion Testing for Tuberculosis. (1964) (0)
- Comparative Reactivities of Non-fibrous and Fibrous Forms of Desoxyribonucleoprotein with Lupus Erythematosus Serum.∗ (1961) (0)
- Regulation of Pathways of Lymphocyte Differentiation by the Serum Lipoprotein: LDL-In (1980) (0)
- Molecular Biology of Tf (1995) (0)
- Crystal structure of extracellular domain of tissue factor complexes with an inhibitory Fab (1996) (0)
- Methods and compositions for specific coagulation of tumor vasculature (1995) (0)
- Plasma dependent cellular cytotoxicity: Anovel tumorcidal activity of the monocytic cell lineage (1992) (0)
- The Effect of Grp78 Inhibition on Tissue Factor Gene Expression, Procoagulant Activity, and Factor Xa Generation. (2004) (0)
- Oligosaccharide Expression and Modification Defines Novel Targets within the Vascular Tree: Selective Chondroitin Sulfate C Expression in the Tumor Microenvironment Generates a Novel Target of Otherwise Constitutive Receptors. (2004) (0)
- Substantially pure human proteinlymphokin and its use (1988) (0)
- TRANSCRIPTION OF FACTOR X 225 the effects of vitamin K and warfarin on the expression of the factor X gene in Hep G 2 cells by measuring the steady state levels of factor X mRNA (2005) (0)
- Carcinoembryonic Antigen (CEA) in Clinical Diagnosis. (1973) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Thomas Scott Edgington?
Thomas Scott Edgington is affiliated with the following schools:
